Neoleukin Therapeutics (NLTX) Short Interest Ratio & Short Volume

Short interest is the volume of Neoleukin Therapeutics shares that have been sold short but have not yet been covered or closed out. As of November 30th, investors have sold 26,400 shares of NLTX short. 0.35% of Neoleukin Therapeutics' shares are currently sold short. Learn More on Neoleukin Therapeutics' current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. NLTX shares currently have a short interest ratio of 1.0. Learn More on Neoleukin Therapeutics's short interest ratio.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.35% of Neoleukin Therapeutics' floating shares are currently sold short.

Neoleukin Therapeutics saw a decline in short interest in November. As of November 30th, there was short interest totaling 26,400 shares, a decline of 4.0% from the previous total of 27,500 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Neoleukin Therapeutics currently has issued a total of 9,398,000 shares. Some of Neoleukin Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Neoleukin Therapeutics currently has a public float of 7,440,000 shares.

0.35% of Neoleukin Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Neoleukin Therapeutics: Kamada Ltd. (0.12%), Erasca, Inc. (10.56%), Verrica Pharmaceuticals Inc. (15.09%), Renovaro Inc. (2.16%), CorMedix Inc. (17.11%), Akebia Therapeutics, Inc. (6.54%), ESSA Pharma Inc. (1.74%), Terns Pharmaceuticals, Inc. (10.70%), XOMA Co. (2.42%), Ventyx Biosciences, Inc. (17.54%),

As of the most recent reporting period, the following stocks had the largest short interest positions: RTX Co. ($6.17 billion), Canadian Natural Resources Limited ($3.99 billion), T-Mobile US, Inc. ($3.78 billion), Charter Communications, Inc. ($3.37 billion), Coinbase Global, Inc. ($2.89 billion), Suncor Energy Inc. ($2.83 billion), Occidental Petroleum Co. ($2.64 billion), Tractor Supply ($2.31 billion), Royal Caribbean Cruises Ltd. ($1.73 billion), and Rivian Automotive, Inc. ($1.71 billion). View all of the most shorted stocks.

Short selling NLTX is an investing strategy that aims to generate trading profit from Neoleukin Therapeutics as its price is falling. NLTX shares are trading down $0.94 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Neoleukin Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of NLTX, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including NLTX, twice per month. The most recent reporting period available is November, 30 2023.